The aim of this study was to evaluate the overexpression of genes central to cell survival and angiogenesis to enhance the function of human late outgrowth endothelial progenitor cells (EPCs) and their utility for infarct recovery. Ischemic myocardial injury creates a hostile microenvironment, which is characterized by hypoxia, oxidative stress, and inflammation. The infarct microenvironment prevents adhesion, survival, and integration of cell transplants that promote neovascularization. EPCs are dysfunctional as a result of risk factors in cardiovascular patients. Protein kinase B (Akt) and heme-oxygenase-1 (HO-1) are intracellular proteins that play an important role in angiogenesis and cell survival. Late outgrowth EPCs transduced ex vivo with Akt and HO-1 demonstrate improved adhesion to extracellular matrix, improved migration toward human cardiomyocytes, and an improved paracrine profile under stress. Enhanced late outgrowth EPCs reduce the tumor necrosis factor-α (TNF-α) burden both in vitro and in vivo, attenuating nuclear factor-κB (NF-κB) activity and promoting cell survival. Akt and HO-1 enhance late outgrowth EPC neovascularization, resulting in improved cardiac performance and reduced negative remodeling after myocardial infarction in nude mice. Alteration of the infarct microenvironment through gene modification of human late outgrowth EPCs enhances the function and integration of transplanted cells for restoration of cardiac function.
INTRODUCTION
(EPCs) (2) are of bone marrow origin and play an important role in reendothelialization of injured vessels and neovascularization of ischemic tissue (9, 19) . EPCs Myocardial ischemia results in cell death. Inflammation of the ischemic zone is necessary to remove are dysfunctional in cardiovascular patients compared to healthy subjects, limiting the therapeutic potential of this necrotic material, but it also contributes to oxidative and inflammatory stress, which exacerbates secondary necro-cell type (9, 19) . Research into EPCs has also been hindered by the controversy in defining EPC ontogeny, lin-sis and negative remodeling (39). Revascularization of the ischemic and infarct border zone salvages myocar-eage, and physiology (2, 4, 34) . However, strategies aimed at increasing the therapeutic utility of EPCs by dial tissue and limits stress and negative remodeling (9). Without reperfusion, infarct healing is limited and the genetic means still hold promise for rejuvenating or enhancing EPCs of cardiovascular patients. risk of heart failure rises. Reparative cells in the myocardium or from the circulation release paracrine factors Protein kinase B (Akt) is associated with neovascularization and vessel stability (26) . Akt loss of function that promote revascularization and enhance myocardial recovery (9, 19) . Circulating endothelial progenitor cells studies result in concurrent loss of EPC motility, reduced nitric oxide bioavailability, and accelerated necrosis in and every 3 days thereafter. Progenitor cell colonies appeared 15-20 days after initial seeding and were ischemic hind limb models (1) . Gnecchi et al. (15) previously used rodent mesenchymal stem cells (MSCs) expanded to the third passage in fibronectin-coated dishes. Late outgrowth EPCs were used in the fourth or expressing constitutively active Akt for ischemic injury recovery, revealing the importance of paracrine contri-fifth passage for experimental protocols. Human cardiomyocytes were purchased from a commercial supplier butions in cell-based therapy and establishing the paracrine hypothesis. However, the paracrine effects of (PromoCell, Heidelberg, Germany) and cultured according to the company's recommendations. EPCs are still being elucidated and have been shown to play an important role in wound healing, which includes Late outgrowth EPCs were washed once and cultured in minimal basal media (EBM; Lonza) for 24 h to mini-actions on multiple cell types (10, 22, 45) , and although MSC differentiation to vascular endothelium can occur, mize potential confounding growth factor effects from the rich EGM-2 media, then transplanted to the ischemic it has been an inconsistent finding among researchers (23, 28, 38) . myocardium in vivo or exposed to a simulated infarctlike environment (IE) in vitro. The in vitro IE was The stress-induced cytoprotective protein hemeoxygenase-1 (HO-1) also has a role in endothelial created by incubating late outgrowth EPCs or human cardiomyocytes with human tumor necrosis factor-α protection and function, with particular emphasis on neovascularization recently reviewed by Dulak et al.
(TNF-α) (20 ng/ml; #210-TA, R&D Systems, Minneapolis, MN, USA) (3, 17, 32, 43) and hydrogen peroxide (12). In HO-1 knock-out mice, EPC tube formation and migration were impaired, in part due to an abnormal (500 µM; Sigma-Aldrich, St. Louis, MO, USA) (13,18, 21, 44) in an external humidified hypoxic environment response to stromal cell-derived factor-1α (SDF-1α) (11). After hind limb ischemia in rodents, blood flow of 1% O 2 and 5% CO 2 (8, 24, 27, 40) . Glass-bottom delta-T dishes (Bioptechs, Butler, PA, USA) were precoated recovery was impaired in the presence of an HO-1 inhibitor (29) , whereas transient overexpression of HO-1 in with 100 µl of Geltrex TM (growth factor-reduced matrix gel; Invitrogen, Burlington, ON, Canada) in EBM. Gel-postischemic tissue promoted recovery and capillary density, partially through stem/progenitor cell recruit-trex TM was added to dishes on ice, leveled with a circular level for 10 min, and incubated at 37°C to solidify on a ment (25, 41) . HO-1 expression in rodent MSCs was also shown to enhance the benefit of cell therapy (42) . level surface for 30 min prior to use. Three-dimensional late outgrowth EPC culture (capillary-like tube forma-We previously established a codependency between Akt and HO-1 in cellular protection and function in tion assay) was performed by uniformly seeding late outgrowth EPCs. The duration of IE exposure was as human smooth muscle cells (6). We postulate that the combined expression of these two central regulators of follows: MTT assay, 24 h; nuclear factor κ-light-chainenhancer of activated B cells (NF-κB) analysis, 6 or 24 neovascularization and cellular protection could provide human late outgrowth EPCs with an enhanced functional h; oxidative stress analysis, 6 h; tube formation analysis, 6 h; adhesion assay, 2 h; migration assay, 30 min for ability in the infarct microenvironment. lower chamber and 16 h for the upper chamber.
MATERIALS AND METHODS

Retroviral Transduction Human Late Outgrowth EPCs and Cardiomyocytes
Human late outgrowth EPCs were obtained from the Late outgrowth EPCs were plated in EGM-2 media at 20-30% confluence. After 24 h, cells were transduced mononuclear fraction of whole peripheral blood. cens green fluorescent protein (AcGFP1) was amplified General nonspecific oxidation was recorded in the FL1 from pIRES2-AcGFP1 (Clontech) by PCR using EcoRIchannel (green) as CM-H 2 DCFDA was oxidized to containing primer (5′-ATACCGGAATTCCAACCATG dichlorodihydrofluorescein (DCF), while the oxyradical-GTGAGCAAGGGC-3′) and SacII-containing primer favored oxidation of DHE to ethidium was recorded in (5′-CTGTCCCCGCGGTCACTTGTACAGCTCATC-3′). the FL4 channel (red).
The PCR product was digested with EcoRI-SacII and Western Immunoblot ligated into EcoRI-SacII digested pIRES-Luc to generate pGFP-IRES-Luc. The 2.9-kb EcoRI-SalI fragment Late outgrowth EPC or Akt/HO-1 EPC lysates were containing cassette GFP-IRES-Luc was ligated with prepared using TPER protein extraction reagent (Pierce, EcoRI-XhoI digested vector pLenti-linker to generate Rockford, IL, USA) containing protease and phospha-pLenti-GFP-IRES-Luc. Subsequently, a pLenti∆CMVtase inhibitor cocktails (Sigma). Protein concentration GFP-IRES-Luc was constructed by replacing a ClaI-SpeI was determined using the Bradford or Lowry method.
(bases: 1824-2474) fragment of pLenti-GFP-IRES-Luc Cardiac tissue was excised, snap frozen, and pulverized with ClaI-SpeI PCR amplification products (bases: frozen with mortar and pestle. Protein samples (25 µg) 2392-2474) to delete the CMV promoter. pLenti∆CMVwere denatured in Laemmli buffer, resolved by 10% NF-κB-GFP-IRES-Luc was then constructed by insertsodium dodecyl sulfate polyacrylamide gel electrophoreing the NF-κB binding sequences of the human vascular sis (SDS-PAGE), and transferred to polyvinylidene fluocell adhesion molecule (VCAM) promoter (CTGGGTT ride (PVDF) membrane (Immobilon-P, 0.45 µm, TCCCCTTGAAGGGATTTCCCTC) into the vector Millipore, Billierica, MA, USA Network approved all experimental procedures accordwere precoated in 96-well plates. EPCs were detached ing to the National Institutes of Health Guidelines for and resuspended in EBM; 1 × 10 5 EPCs or Akt/HO-1 the Care and Use of Laboratory Animals. Nude female EPCs were seeded into each well and incubated for 2 h mice (18-20 g, NU/NU CD1 mice) were purchased either in basal or IE conditions. Nonadherent cells were from the National Cancer Institute (Bethesda, MD, aspirated, and wells were gently washed three times.
USA). Nude mice were intubated and ventilated with Adherent cells were lysed and quantified using CyQuant 2% isoflurane prior to thoracotomy and permanent liga-GR dye (Invitrogen) at a fluorescent reading of 485ex/ tion of the left anterior descending coronary artery, as 520em in a FLUOStar Optima plate reader.
previously described (37) . Pallor and echocardiography confirmed ϳ35% infarction of the left ventricle. At the Migration Assay time of occlusion, 500,000 genetically modified human EPC migration was assessed in accordance with the male EPCs in a volume of 15 µl or 15 µl of medium recommended directions of the supplier (#ECM 510, control were injected into three sites across the myocar-Chemicon). Either normal EBM media or IE was present dial infarct border zone (defined as the area between in the lower portion of a modified Boyden chamber in pallor and red color areas) with a 27-gauge insulin neethe presence of 10% fetal bovine serum (FBS; HyClone, dle. Five groups were analyzed: an equivalent medium Thermo-Fisher Scientific, Ottawa, ON, Canada) as a volume without cells (medium group), EPCs (EPC nonspecific, universal chemoattractant. Otherwise, 5 × group), Akt EPCs (Akt group), HO-1 EPCs (HO-1 10 4 EPCs or Akt/HO-1 EPCs were plated into the lower group), and Akt/HO-1 EPCs (Akt/HO-1 group). chamber in EBM and allowed to adhere for 1 h. To Echocardiography at post-MI day 7 and 14 was used induce secretion of infarct-stimulated autocrine/parato determine heart rate, fractional shortening (FS), left crine factors, the cells were then exposed to IE for 30 ventricular end-diastolic diameter, and left ventricular min, after which 5 × 10 4 EPCs or Akt/HO-1 EPCs were end-systolic diameter. Mice were sedated with isofluradded to the upper chamber and allowed to migrate ane. Heart rates were above 450 bpm, and left parasterthrough an 8-µm polycarbonate barrier toward the lower nal images were taken in the right lateral decubitus chamber overnight (16 h) under nominal or IE condiposition using a 13-MHz transducer (Sequioa C256 and tions. EPCs or Akt/HO-1 EPCs in the upper chamber 15L8, Acuson, Mountain View, CA, USA). Images were were then discarded, and cells that migrated to the stored as short-axis, two-dimensional, digital loops and underside of the filter were detached, lysed, and quanti-M-mode images at the midpapillary level of the left venfied using CyQuant GR dye (Invitrogen) at a fluorestricle. At 14 days, pressure-volume analysis was carried cent reading of 485ex/520em in a FLUOStar Optima out under positive pressure ventilation using a micromaplate reader.
nometer conductance 1.4-Fr catheter (Millar Instruments, Houston, TX, USA). Pressure-volume loops Murine Macrophages were determined during a transient apnea. Preload C57BL/6 mice (25-30 g; The Jackson Laboratory, recruitable stroke work (PRSW) and end-systolic pres-Bar Harbor, MA, USA) were sacrificed by CO 2 inhalasure-volume relationship (ESPVR) loops were meation. The peritoneal exudates were collected on ice after sured during vena cava occlusion. Load-dependent intraperitoneal injection of 3× 5 ml complete medium analysis was used to determine ejection fraction and (RPMI-1640, Sigma) with 10% FBS, L-glutamine positive developed pressure over time (+dP/dt). (HyClone), penicillin, and streptomycin (Invitrogen). The exudates were centrifuged (240 × g, 10 min, 4°C),
Immunohistochemistry and Image Analysis resuspended in complete medium, counted, and plated (2 × 10 5 cells/dish) in the center of glass-bottom dishes For late outgrowth EPC retention analysis, paraffinembedded (5 µm thick) sections were incubated with (MatTek, Ashland, MA, USA). After 2 h at 37°C in a 95% air, 5% CO 2 incubator, adhered peritoneal macro-primary antibody specific to human mitochondria (1: 100; #MAB1273, Millipore/Chemicon International). phages (MΦs) were washed twice with phosphatebuffered saline (PBS) to remove nonadherent cells, sup-Total late outgrowth EPC retention was assessed by measuring the number of positively stained cells per plemented with fresh complete medium including 1 µg/ml microscopic field (200× equal to 0.4 mm 2 ) in five fields 16 h at 4°C. Peritoneal MΦs or late outgrowth EPCs were incubated for 1 h in minimal medium, and beads per slide.
For apoptosis analysis, terminal dUTP nick-end were added in a ratio of 1000 beads/cell. After 60 min at 37°C or 4°C (control), cells were washed four times labeling (TUNEL) assay was performed on tissue sections with an in situ Cell Death Detection kit (Roche) with HBSS, detached using HyQTase TM solution (20 min, 37°C; HyClone), and pelleted by centrifugation. according to the instructions of the manufacturer. Apoptotic cell death was determined by counting the number Peritoneal MΦs or late outgrowth EPCs were resuspended in HBSS and analyzed by FACS (FC500, Beck-of TUNEL-positive nuclei per microscopic field (200× equal to 0.4 mm 2 ) in five fields per slide.
man Coulter, Mississauga, ON, Canada) flow cytometry. The mean fluorescence intensity of cells was compared For angiogenesis analysis, paraffin-embedded (5 µm thick) sections were incubated with primary antibody spe-to control cells previously incubated at 4°C with or without beads, and no difference in EPC groups con-cific to von Willebrand factor (1:100; vWF-FVIII, Invitrogen). The density of blood vessels was assessed by firmed the absence of phagocytosis (data not shown). measuring the number of positive signals per microscopic Late Outgrowth EPC Immunophenotyping/Antigenicity field (200× equal to 0.4 mm 2 ) in five fields per slide.
by FACS Flow Cytometry For oxidative stress analysis, paraffin-embedded (5 µm thick) sections were incubated with primary anti-Late outgrowth EPCs near 80% confluence were detached with HyQTase TM (Hyclone) and washed once with body specific to the oxidized epitope (8-OH deoxyguanosine) and not the 2′-deoxyguanosine (1:50; #ab26842, PBS-5% FBS. Late outgrowth EPCs were resuspended in 90 µl PBS-5% FBS and 10 µl of monoclonal-conju-Abcam, Cambridge, MA, USA). The area of oxidative stress was assessed by positive signals per microscopic gated antibody or isotype control. We used the following antibodies with their respective manufacturer-recom-field (200× equal to 0.4 mm 2 ) in five fields per slide.
For scar analysis, the heart (after functional analysis) mended isotype controls to immunolabel late outgrowth EPCs prior to transduction: CD31-fluorescein isothiocy-was formalin-fixed with diastolic pressure at 20 mmHg. After 48-h fixation, the heart was sectioned in 1-mm-anate (FITC; #BD-555445), CD34-FITC (#BD-555821), CD54-phycoerythrin (PE; #BD-555511), CD106-FITC thick slices (5-6 sections). We measured all five heart sections from the apex side to calculate the scar area.
(#BD-551146), CD184-allophycocyanin (APC; #BD-555976), 140b-PE (#BD-558821), all from BD Biosci-Specifically, both apical and basal sections were digitally photographed (Coolpix, Nikon, Tokyo, Japan). ences; CD105-PE (#FAB10971P), CD117-PE (#FAB332P), CD202b-APC (#FAB3131A), CD144-PE (#FAB9381P), ImageJ Software was used for morphometric analysis. The epicardial surface areas of the left ventricular free CD309-PE (#FAB357P), all from R&D Systems; CD133 (#130-090-826, Miltenyi Biotec, Auburn, CA, wall (LVFW) and any scar tissue in the LVFW were measured by planimetry. The surface areas of the epicar-USA); and combined CD14-PE/CD45-FITC Multimix (Dako, Mississauga, ON, Canada). Late outgrowth EPCs dial scar tissue and the LVFW were measured as the sum of the epicardial length times the section thickness were placed in the dark on ice with shaking for 1 h. Late outgrowth EPCs were washed twice with PBS-5% FBS (1 mm). The surface area percentage of scar tissue in the LVFW was calculated as follows: (epicardial scar and examined by FACS. The percentage of positive late outgrowth EPCs was calculated using the conjugate area)/(epicardial LVFW area) × 100.
isotype negative controls according to the method of Phagocytosis Assessment
Overton (31) . Peritoneal MΦs or late outgrowth EPCs were grown Secretome Protein Array for 1 h in minimal medium. India ink (stock solution in PBS; #3398, Speedball, Kingston, ON, Canada) was Four independent transductions of late outgrowth EPCs were performed in T25 flasks; each flask was split added in a 1:4000 dilution to the medium. Peritoneal MΦs or late outgrowth EPCs were incubated for 60 min into three wells of a six-well plate. After exposure to the IE for 24 h, media were collected, pooled, and concen-at 37°C or 4°C (for nonspecific binding control), washed four times with HBSS, and assessed by phase contrast trated using an Amicon Ultra-15, 3 kDa concentrator (#EFC-900308, Millipore) by centrifugation at 4000 × g microscopy. Yellow-green FluoSpheres (505/515 nm, 0.2 µm diameter; Invitrogen) were washed once in PBS for 60 min at 4°C. EPC or Akt/HO-1 EPC lysates were collected by adding 50 µl/well of PBS with protease and (16,000 × g, 10 min, 4°C), resuspended, and sonicated to dissolve aggregates and used either directly or with phosphatase inhibitor cocktails (Sigma), 0.5% Triton X-100, and 0.5% NP-40 detergents. Lysates were collected prior opsonization using 5% normal goat serum (Jackson ImmunoResearch, West Grove, PA, USA) in PBS for and homogenized with a plastic Eppendorf pestle, and centrifuged for 5 min at 10,000 × g at 4°C. Conditioned also measured a marked reduction in the amount of intracellular oxidative stress in Akt/HO-1 EPCs as deter-media (undiluted) and supernatant (200 µg/ml) were snap frozen and shipped frozen to RayBiotech, Inc.
mined by the attenuated intensity of the redox-sensitive fluorochromes CM-H 2 DCFDA and DHE (Fig. 2F) . In (Norcross, GA, USA) for proteome profiling using a human G-series 2000 array. Samples were internally addition, levels of prosurvival hepatocyte growth factor (HGF), interleukin-8 (IL-8), and osteoprotegerin were normalized and data were presented as integrated density values (IDVs). We used a weighted measure to elevated in the medium as determined by the Raybiotech proteome array (Table 1) . Surprisingly, TNF-α in the assign priority to results based on total detectability, arithmetic difference, and relative difference in compari-medium 24 h after exposure to the IE was reduced by ϳ50% in Akt/HO-1 EPCs ( Table 2) . Taken together, son to parallel control.
these data demonstrate that a pleiotropic benefit is con-Statistical Analysis ferred by Akt and HO-1 expression in EPCs that includes All values are expressed as mean ± SD. Comparisons modification of paracrine factors of the secretome. of two parameters used unpaired t-test and parameters among 3-5 groups were analyzed by one-way ANOVA Adhesion and Migration of Akt/HO-1 EPCs for single-factor or two-way ANOVA for two-factor Are Augmented variables with repeated measures, followed by Newman-Keuls or Bonferroni multiple comparisons. Differences
The ability of late outgrowth EPCs to form tubes in were considered statistically significant at a value of Matrigel (Fig. 3A , i) was almost completely lost after p < 0.05.
exposure to the stress of the IE (Fig. 3A, ii) . However, the formation of capillary-like tubes under stress was RESULTS preserved in Akt/HO-1 EPCs (Fig. 3A, iii) . Considering Akt/HO-1 EPCs Survive in a High-Stress the evidence for reducing free radicals and the toxic In Vitro Environment cytokine TNF-α, it was not clear whether improved tube formation was simply a consequence of cell survival. Human late outgrowth EPCs were characterized for antigens and endothelial function ( Fig. 1) and were Therefore, since adhesion to extracellular matrix (ECM) is an important function of cells forming neovessels and highly amenable to viral-mediated gene expression ( Fig.  2A-C) . Transduction efficiency was determined by is necessary for juxtacrine signaling to native vessels for angiogenesis after transplantation, we tested whether green fluorescent protein (GFP) analysis ( Fig. 2A) . Western blot analysis of Akt/HO-1 EPCs demonstrated this was altered in Akt/HO-1 EPCs. Under stress-free conditions, adhesion to ECM proteins, with the excep-a significant fourfold elevation in constitutively active Akt and twofold increase in HO-1 expression ( Fig. 2B , tion of collagen I, was significantly improved in Akt/ HO-1 EPCs (data not shown). Importantly, the capacity C). To determine whether Akt/HO-1 EPCs could improve functional recovery, we first assessed their of late outgrowth EPCs to adhere to ECM proteins was impaired by the IE conditions (Fig. 3B) . In contrast to capacity to resist a high-stress "infarct-like" microenvironment (IE) in vitro. Late outgrowth EPCs were observations under basal conditions, Akt/HO-1 EPCs were significantly more adherent to collagen I in the IE. exposed to the upper range of physiological levels of human TNF-α (20 ng/ml) and H 2 O 2 (500 µM) in a hyp-Further, these Akt/HO-1 EPCs elicited greater adherence to some (vitronectin, tenascin, laminin, and colla-oxic (1% O 2 ) atmosphere. This hostile microenvironment was used to simulate the combined inflammation, gen II) but not all (fibronectin and collagen IV) ECM proteins in the IE. In part, this could be due to an eleva-oxidative stress, and hypoxia that EPCs would be exposed to after clinical transplantation. Mitochondrial tion in the adhesion molecules activated leukocyte cell adhesion molecule (ALCAM), platelet endothelial cell reductase activity was determined by quantification of tetrazole conversion to formazan by viable late out-adhesion molecule (PECAM1), and intercellular adhesion molecule (ICAM2) ( Table 1) or to the moderate growth EPCs at 80% confluence after exposure to an in vitro IE (MTT assay). The viability of late outgrowth 17% increase in E-selectin measured in cell lysates from Akt/HO-1 transduced EPCs (data not shown). EPCs was reduced to <50% as determined by MTT assay (Fig. 2D) . In contrast, mitochondrial reductase Cellular migration is also an important component of neovessel formation. Under basal conditions, Akt/HO-1 activity was preserved (>70%) in Akt/HO-1 EPCs. Further, there was a significant reduction in the transactiva-EPCs had no advantage over EPCs in their ability to migrate toward a general stimulus of 10% serum (Fig.  tion of the redox-and inflammatory-sensitive transcription factor NF-κB in Akt/HO-1 EPCs (Fig. 2E, i) . This was 3C). Not surprisingly, the migration of EPCs was severely reduced by ϳ70% with a stimulus of 10% also accompanied by rapid phosphorylation and subsequent degradation of the IκB protein ( Fig. 2E, ii) . We serum with IE ( Fig. 3C) . Unexpectedly, Akt/HO-1 EPCs gained no advantage in migration toward serum in the used human cardiomyocytes exposed to the IE without serum as the sole stimulus for late outgrowth EPC IE (Fig. 3C ). However, multiple factors are reportedly responsible for migration or chemoattraction of EPCs to migration. The presence of human cardiomyocytes exposed to the IE stimulated migration of EPCs (Fig.  the infarct. Indeed, it is generally accepted that cardiomyocytes under ischemic stress or after reperfusion 3C). This chemotactic effect was significantly augmented for Akt/HO-1 EPCs (Fig. 3C) . Further, EPCs injury release chemotactic factors to mobilize resident and peripheral circulating EPCs. To better simulate a drawn to sites of ischemic injury from the peripheral blood or after transplantation must communicate with genuine secretome of cardiomyocytes under stress, we each other through chemotactic stimuli to align for neo-we identified the number of human late outgrowth EPCs within the peri-infarct area of the mouse heart 14 days vessel formation. As such, we also examined the effect of EPCs in an IE as a source of paracrine factors that after implantation. The cells were identified morphologically as integrating into small vessels of the heart (Fig.  could promote migration. Those Akt/HO-1 EPCs demonstrated significantly greater migration to other Akt/ 4A). The number of Akt/HO-1 EPCs was highest (Fig.  4B , C) compared with all control groups (Fig. 4A, C) , HO-1 EPCs in an IE (Fig. 3C) . These data suggest that the collective presence of postinfarct cardiomyocytes though the Akt EPC and HO-1 EPC groups did demonstrate higher cellular survival than the EPC control ( Fig.  and Akt/HO-1 EPCs could potentially attract additional cells through autocrine/paracrine signaling (see Table  4C ). Blood vessel density overall was elevated in the nude mice hearts in the Akt/HO-1 EPC transplant group 1). Taken together, improved adhesion, survival, migration, and an altered secreted protein profile in Akt/HO-to a greater extent than with either gene alone (Fig. 4D , E). All late outgrowth EPC groups revealed greater 1 EPCs could result in greater cell integration at the site of injury after MI. To test this proof-of-principle, we blood vessel density compared with the medium control group. examined the cells in a nude mouse model of MI.
Apoptotic cells in the infarct and border region were Transplantation of Akt/HO-1 EPCs After MI Improves identified 14 days after implantation (Fig. 5A ). The Cardiac Recovery in Mice number of TUNEL-positive nuclei was significantly higher in mice treated with medium compared to mice Akt/HO-1 EPCs Show Improved Survival and Neovessel Formation. Using anti-human mitochondria antibodies, treated with EPCs, Akt EPCs, or HO-1 EPCs (Fig. 5B ). TUNEL-positive nuclei were significantly fewer in the added benefit achieved through Akt/HO-1 gene expression is a reduction in TNF-α. To determine whether Akt/HO-1 EPC group than either the Akt EPC or HO-1 EPC group. Apoptosis at 2 weeks was predominately in these molecular effects translated to functional improvement, we next detailed functional cardiac recovery. host tissue in the peri-infarct region and was contained by the transplantation of Akt/HO-1 EPCs.
Akt/HO-1 EPCs Confer Improved Cardiac Function To identify the mechanism for superior survival of After MI. A progressive alteration of cardiac function host cells by Akt/HO-1 EPCs compared to EPCs, we following cell transplantation was determined using examined the peri-infarct region for oxidative stress. echocardiography. Coronary artery ligation resulted in a Immunolabeling identified the oxidized derivative of significant decrease in left ventricular (LV) function and deoxyguanosine, 8-hydroxydeoxyguanosine, that accuincrease in dilatation after MI. At 7 days post-MI, the mulates in the nuclear and mitochondrial DNA of cells transplantation of Akt/HO-1 EPCs demonstrated higher with redox imbalance. The degree of oxidative stress in fractional shortening (FS) compared with Akt EPCs or the peri-infarct region was significantly reduced in the HO-1 EPCs (Fig. 6A ). The functional preservation was hearts receiving EPCs and those receiving Akt/HO-1 better in the Akt EPC group than in the EPC group. No EPCs compared to media control (Fig. 5C ). The reducdifference was observed at day 7 between the HO-1 EPC tion in oxidative stress was not different between EPCs group and the EPC group, and neither was significantly and Akt/HO-1 EPCs. This suggests that late outgrowth improved by comparison to medium alone. By day 14 EPC transplantation reduces the accumulation of free post-MI, the Akt EPC and HO-1 EPC groups demonradical stress, but is unlikely the reason for greater benestrated better cardiac function with higher FS than the fit achieved by EPCs expressing Akt/HO-1. However, EPC group, which also demonstrated improved function early experiments 3 days post-MI revealed a significant compared with the medium control group. However, the decline in the amount of TNF-α-immunoreactive protein Akt/HO-1 EPC group maintained cardiac functional within the ischemic area where Akt/HO-1 EPCs were recovery with significantly higher FS than all controls implanted (Fig. 5D ). This 50% reduction in TNF-α was (Fig. 6A ). also observed in our in vitro analysis with high levels of
On day 14 after MI, cardiac function was evaluated TNF-α ( Table 2 ) added to the medium as a component using a pressure-volume catheter under load-dependent of the IE. TNF-α is reduced in part through the secretion and load-independent conditions. Compared to medium of soluble TNF receptors. The amounts of soluble TNF and EPCs, Akt EPC, HO-1 EPC, and Akt/HO-1 EPC receptor 1A/B and 6 were elevated in Akt/HO-1 EPCs groups improved load-dependent parameters, including in vitro (Table 1) . Taken together, EPCs effectively ejection fraction ( Fig. 6B ) and end-systolic/end-diastolic buffer the redox imbalance of post-MI hearts, but the volumes (Fig. 6C, D) , as well as load-independent parameters, including end-systolic elastance (ESP/ESV Akt EPC, HO-1 EPC, and EPC treatments did reduce enddiastolic volume relative to medium, but no synergistic slope, ESPVR) ( Fig. 6F ) and preload recruitable stroke work (PRSW) (Fig. 6G) . Importantly, the Akt/HO-1 benefits were found for this parameter (Fig. 6D ). EPC group significantly improved these parameters compared with either the Akt EPC or HO-1 EPC group, with Akt/HO-1 EPCs Reduce Myocardial Scarring and Wall Thinning. Myocardial scar tissue was analyzed the exception of end-diastolic volume. Akt/HO-1 EPC, ( Fig. 7A-E) , and the scar, border region, and normal EPCs, Akt EPCs, or HO-1 EPCs. Notably, scarring was less extensive and thicker in animals that received the myocardial tissue were identified with Masson's trichrome staining (Fig. 7F-J) . Quantitative planimetry Akt/HO-1 EPCs (Fig. 7J ) in comparison to Akt EPCs or HO-1 EPCs (Fig. 7H, I) , which suggests that the combi-revealed more extensive (Fig. 7K ) and thinner ( Fig. 7L ) scars in medium control animals than in those receiving nation of Akt and HO-1 enhanced the capability of late outgrowth EPCs to stabilize the infarct and prevent scar therapeutic approach allows for adaptation of the local microenvironment that is unavailable with antibody expansion and ventricular dilatation, in agreement with functional parameters. therapy. In this way, transplanted cells could protect against pathophysiological levels of TNF-α without DISCUSSION abrogating its physiological purposes and could thus offer a superior alternative. To our knowledge, this is the This study demonstrates that late outgrowth EPCs expressing Akt and HO-1 are better able to prevent car-first evidence that cell therapy is capable of providing a "molecular sink" to reduce levels of negative cytokines diac dysfunction after an MI. Late outgrowth EPCs expressing Akt and HO-1 are better able to adhere, sur-in addition to the added benefit of proangiogenic factors. The mechanisms of reducing, sequestering, or limiting vive, and integrate functionally after MI. Transplantation of late outgrowth EPCs to the postinfarct production of TNF-α, and other toxic products of inflammation, require more study and should be a focus environment first requires adhesion to the ECM for cell survival and integration. Following cell adhesion, late of future work in cell-based therapies.
Here we also provide additional insight toward the outgrowth EPCs migrate to form neovessels and communicate through paracrine signaling to promote host mechanisms of enhanced late outgrowth EPC function beyond survival, namely improved adhesion and migra-angiogenesis. Our study directly targeted upstream intracellular mechanisms important for late outgrowth EPC tion. Our in vitro observations of enhanced ECM adhesion and migration toward human cardiomyocytes or function as a strategy to enhance the therapeutic potential of late outgrowth EPCs.
other EPCs under stress account, at least in part, for the greater integration of transplanted cells in vivo after MI. Expression of Akt/HO-1 attenuates intracellular oxidative stress and the proinflammatory transcription fac-
The mechanisms by which Akt/HO-1 EPCs achieve enhanced adhesion through binding the ECM remain to tor NF-κB in late outgrowth EPCs. This could, at least in part, be a component of improved function in the be established. However, E-selectin levels were elevated in Akt/HO-1 EPCs (data not shown), which is known infarct environment. Naturally, NF-κB is likely not the sole regulated pathway, though hypoxia acts through to augment EPC function (30) . Promoting migration for neovessel formation through paracrine communication Akt-mediated NF-κB to regulate neovascularization (35) . For example, TNF-α can also activate hypoxia between late outgrowth EPCs and highly stressed human cardiomyocytes is intriguing. Likely, this is mediated by inducible factor 1α (HIF1-α) in an NF-κB-dependent manner, even under normoxic conditions (20, 46) . Early a combination of autocrine/paracrine factors, such as the chemokine (C-C motif) ligand 3 (CCL3) and CCL4, post-MI activation of NF-κB is heavily influenced by inflammation and the levels of TNF-α released by resi-which were significantly higher in Akt/HO-1 EPCs ( Table 1 ). The role of these molecules may have been dent mast cells and other infiltrating leukocytes. TNF-α negatively influences EPC function, neovascularization, undervalued as bystanders of inflammation since they are better known for their role in leukocyte trafficking. and myocardial recovery after infarction (16). This study provides a mechanism for reducing cardiac dysfunction Infarct recovery requires overlapping steps of inflammation, repair, and perhaps even limited regeneration in the with Akt/HO-1 EPCs through reduced oxidative stress in addition to the elimination of TNF-α by ϳ50% both remodeling processes, much of it requiring autocrine/ paracrine coordination. However, identifying the com-in vitro and in vivo. Though at low relative abundance, there was evidence of soluble TNF receptors 1A/B and plex interplay of chemokine signaling is a challenge (22) , particularly in vivo, and may require advanced in 6 being elevated in the medium of Akt/HO-1 EPCs in vitro. As such, other mechanisms may be involved in vivo imaging techniques. Future studies are needed to further identify the detailed intercellular signaling inter-the reduction of TNF-α. As a limitation of our study, we chose TNF-α to represent the stress of inflammation actions between progenitors and differentiated cells, particularly after injury. for its cytotoxic effects in the post-MI environment and have not examined other cytokines (14,17). However, Our study focused on human late outgrowth EPCs, but our results are in agreement with other investigations regulating TNF-α through cells capable of adapting to the local microenvironment could provide a better option implicating Akt and HO-1 in rodent MSC function and ischemic recovery. Our secretome findings are also sup-than direct TNF-α targeting, which has so far produced disappointing clinical outcomes (i.e., RENEWAL) (29) .
ported by previous work, which revealed the importance of factors such as IL-8, platelet-derived growth factor The use of TNF-α antibodies has previously been shown to be effective in preclinical models (5). However, (PDGF), and HGF (10, 22, 44, 45) . However, our secretome data are not in complete agreement with findings achieving the appropriate localized effects is a challenge to clinical antibody therapy, and TNF-α has receptor-identifying the importance of SDF1-α and vascular endothelial growth factor (VEGF) (22) (23) (24) (25) . For example, and dose-dependent physiological roles (36) . A cell-based
